Similarly, in patients with type 2 diabetes, elevated sclerostin levels were demonstrated to be correlated with increased carotid intima-media thickness (cIMT), potentially as a protective mechanism to slow the progression of atherosclerosis [36]. This evidence concerns the gene SOST and atherosclerosis.